HPV self-sampling in Japanese women: A feasibility study in a population with limited experience of tampon use

Journal of Medical Screening

Volumn 23, Issue 3, 2016, Pages 164-170

  Hanley, Sharon J B ^a   Fujita, Hiromasa ^b   Yokoyama, Susumu ^c   Kunisawa, Shiori ^c   Tamakoshi, Akiko ^a   Dong, Peixin ^a   Kobayashi, Noriko ^a   Watari, Hidemichi ^a   Kudo, Masataka ^a   Sakuragi, Noriaki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization   (Japan)

^c Sapporo Industrial Health Management Screening Center   (Japan)

Author keywords

Acceptability; Cervical cancer; Human papillomavirus self sampling; Screening; Tampon use

Indexed keywords

ADULT; FEMALE; HUMAN; JAPAN; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PATIENT ATTITUDE; PROCEDURES; SELF CARE; SPECIMEN HANDLING; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; YOUNG ADULT;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; JAPAN; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; SELF CARE; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84986596654     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141315625702     Document Type: Article

References (39)

1. Globocan 2012, http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (accessed 12 June 2015).
2. Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan, http://ganjoho.jp/reg_stat/statistics/dl/index.html (accessed 12 June 2015).
3. SEER Cancer Statistics, http://seer.cancer.gov/statfacts/html/cervix.html (accessed 12 June 2015).
4. AIHW, http://www.aihw.gov.au/acim-books/ (accessed 12 June 2015).
5. Motoki Y, Mizushima S, Taguri M, et al. Increasing trends in cervical cancer mortality among young Japanese women below the age of 50 years: an analysis using the Kanagawa population-based cancer registry, 1975–2012. Cancer Epidemiol 2015; 39: 700–706.
6. Spence AR, Goggin P and Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 2007; 45: 93–106.
7. Mubiayi N, Bogaert E, Boman F, et al. Cytological history of 148 women presenting with invasive cervical cancer. Gynecol Obstet Fertil 2002; 30: 210–217.
8. Bos AB, Rebolj M, Habbema JD, et al. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 2006; 119: 2372–2375.
9. Waller J, Bartoszek M, Marlow L, et al. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen 2009; 16: 199–204.
10. Oshima S and Maezawa M. Perception of cervical cancer screening among Japanese university students who have never had a pap smear: a qualitative study. Asian Pac J Cancer Prev 2013; 14: 4313–4318.
11. Cadman L, Wilkes S, Mansour D, et al. A randomized controlled trial in nonresponders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening. J Med Screen 2015; 22: 28–37.
12. Oranratanaphan S, Termrungruanglert W and Khemapech N. Acceptability of self-sampling HPV testing among Thai women for cervical cancer screening. Asian Pac J Cancer Prev 2014; 15: 7437–7441.
13. Marlow LA, Wardle J and Waller J. Understanding cervical screening nonattendance among ethnic minority women in England. Br J Cancer 2015; 113(5): 833–839.
14. Montealegre JR, Landgren RM, Anderson ML, et al. Acceptability of selfsample human papillomavirus testing among medically underserved women visiting the emergency department. Gynecol Oncol 2015; 138: 317–322.
15. Virtanen A, Nieminen P, Niironen M, et al. Self-sampling experiences among non-attendees to cervical screening. Gynecol Oncol 2014; 135: 487–494.
16. Ministry of Health, Labour and Welfare, http://www.mhlw.go.jp/stf/shingi/ 2r985200000363zv-att/2r9852000003644k.pdf (accessed 12 June 2015).
17. Hanley SJ, Yoshioka E, Ito Y, et al. HPV vaccination crisis in Japan. Lancet 2015; 385: 2571.
18. Snijders PJ, Verhoef VM, Arbyn M, et al. High-risk HPV testing on selfsampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013; 132(10): 2223–2236.
19. Arbyn M, Verdoodt F, Snijders PJ, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014; 15: 172–183.
20. Schmeink CE, Bekkers RL, Massuger LF, et al. The potential role of selfsampling for high-risk human papillomavirus detection in cervical cancer screening. Rev Med Virol 2011; 21: 139–153.
21. Waller J, McCaffery K, Forrest S, et al. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 2006; 13: 208–213.
22. Vanderpool RC, Jones MG, Stradtman LR, et al. Self-collecting a cervicovaginal specimen for cervical cancer screening: an exploratory study of acceptability among medically underserved women in rural Appalachia. Gynecol Oncol 2014; 132: S21–215.
23. Scarinci IC, Litton AG, Garces-Palacio IC, et al. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta. Womens Health Issues 2013; 23: e123–130.
24. De Alba I, Anton-Culver H, Hubbell FA, et al. Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epidemiol Biomarkers Prev 2008; 17: 2163–2168.
25. Anhang R, Nelson JA, Telerant R, et al. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health (Larchmt) 2005; 14: 721–728.
26. Crofts V, Flahault E, Tebeu PM, et al. Education efforts may contribute to wider acceptance of human papillomavirus self-sampling. Int J Womens Health 2015; 7: 149–154.
27. Cadman L, Ashdown-Barr L, Waller J, et al. Attitudes towards cytology and human papillomavirus self-sample collection for cervical screening among Hindu women in London, UK: a mixed methods study. J Fam Plann Reprod Health Care 2015; 41: 38–47.
28. Hanley SJ, Fujita H, Yokoyama S, et al. The role of HPV self-sampling to increase cervical screening uptake: a study on acceptance, usability and clinical accuracy. Acta Obstetr Gynaecol Jpn 2015; 67: 1012 (ISP-3-9).
29. Cerigo H, Coutlee F, Franco EL, et al. Dry self-sampling versus providersampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec. J Med Screen 2012; 19: 42–48.
30. Dijkstra MG, Heideman DA, van Kemenade FJ, et al. Brush-based self-sampling in combination with GP5þ/6þ-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN. J Clin Virol 2012; 54: 147–151.
31. Szarewski A, Cadman L, Mallett S, et al. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. JMed Screen 2007; 14: 34–42.
32. Kahn JA, Bernstein DI, Rosenthal SL, et al. Acceptability of human papillomavirus self testing in female adolescents. Sex Transm Infect 2005; 81: 408–414.
33. Zehbe I, Moeller H, Severini A, et al. Feasibility of self-sampling and human papillomavirus testing for cervical cancer screening in First Nation women from Northwest Ontario, Canada: a pilot study. BMJ Open 2011; 1: e000030.
34. Sewali B, Okuyemi KS, Askhir A, et al. Cervical cancer screening with clinicbased Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial. Cancer Med 2015; 4: 620–631.
35. Hanley SJ, Yoshioka E, Ito Y, et al. Acceptance of and attitudes towards human papillomavirus vaccination in Japanese mothers of adolescent girls. Vaccine 2012; 30: 5740–5747.
36. Romo LF and Berenson AB. Tampon use in adolescence: differences among European American, African American and Latina women in practices, concerns, and barriers. J Pediatr Adolesc Gynecol 2012; 25: 328–333.
37. Mann L, Foley KL, Tanner AE, et al. Increasing cervical cancer screening among US Hispanics/Latinas: a qualitative systematic review. J Cancer Educ 2015; 30: 374–387.
38. Collins Y, Holcomb K, Chapman-Davis E, et al. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol 2014; 133: 353–361.
39. Glick SB, Clarke AR, Blanchard A, et al. Cervical cancer screening, diagnosis and treatment interventions for racial and ethnic minorities: a systematic review. J Gen Intern Med 2012; 27: 1016–1032.